S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

PHAT Phathom Pharmaceuticals Inc

9.26

0.23 (2.55%)

After Hours

Last Updated: 06:23:39

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Phathom Pharmaceuticals (NASDAQ:PHAT)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Phathom Pharmaceuticals Charts.

Phathom Pharmaceuticals (NASDAQ:PHAT)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Phathom Pharmaceuticals Charts.

Phathom Pharmaceuticals Inc News

Phathom Pharmaceuticals to Report First Quarter 2024 Financial Results and Provide Business Update on Thursday, May 9, 2024
Monday 29 April 2024 (3 days ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Wednesday 3 April 2024 (4 weeks ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
Tuesday 26 March 2024 (1 month ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Friday 8 March 2024 (2 months ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
Friday 1 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Wednesday 14 February 2024 (3 months ago) • GlobeNewswire Inc.

Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Thursday 1 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 16 December 2023 (5 months ago) • Edgar (US Regulatory)

More Phathom Pharmaceuticals Inc News Articles

Woodside Petroleum

AUD vs US Dollar

JP Morgan Chase

Australia And New Zealan...

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions